Last update 19 Jun 2024

Carbon Dioxide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Carbon dioxide (JP17/USP), FT-817
Target-
Mechanism-
Therapeutic Areas
Active Indication-
Inactive Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (18 Jul 2020)
RegulationOrphan Drug (US)
Login to view First Approval Timeline

Structure

Molecular FormulaCO2
InChIKeyCURLTUGMZLYLDI-UHFFFAOYSA-N
CAS Registry124-38-9

External Link

KEGGWikiATCDrug Bank
D00004--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Respiratory DiseasesPreclinical--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
-
180
Air insufflation
(Air for Insufflation)
pcdbmmvvaf(etleyibfcn) = qkopnyzcjw ilobrtvgvp (evqeipjbvx, sskhclpjom - ffzmcfeqce)
-
19 Jan 2022
(Carbon Dioxide Gas for Insufflation)
pcdbmmvvaf(etleyibfcn) = mblzymrqvj ilobrtvgvp (evqeipjbvx, ctfsrnhxdw - xutgvhdyix)
Phase 2
-
gwcovajsor(kblskqczyn) = There was a statistically significant decrease in peripheral blood oxygenation levels over time in the placebo group following allergen inhalation, whereas blood oxygenation was maintained at normal levels in the S1226-treated subjects idockpwtih (dlnoxnhfhb )
Positive
18 Jun 2018
Placebo
Phase 2
10
qzfdrynzos(hiwwrbgdur) = hgvrzjjxys jnawcawsxo (bydnfjwmhp, vwxduhtskf - poccoqnipg)
-
01 May 2018
Not Applicable
-
71
(Bronchoscopic Cryosurgery with Carbon Dioxide)
hmtvjtmanp(ctdzhrtebe) = kcdrxxjogx zfrckagznl (azojjbgutg )
-
05 Dec 2016
Phase 1
36
hitvblrdzx(rmlzcsnbzl) = A total of 28 adverse events were reported, and all were judged mild in severity. Twenty-four adverse events occurred in the S-1226 cohort, of which five were considered remotely related and six possibly related to S-1226. fojydiqvvj (mernvdkcrf )
Positive
28 Jul 2016
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free